Skip to main content

Find Clinical Trials

Home
Conditions
Stage IIIB Breast Cancer

Clinical trial condition

Stage IIIB Breast Cancer

Explore clinical trials studying Stage IIIB Breast Cancer. Study availability and eligibility vary by location and protocol.

103 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IIIB Breast Cancer trial results

Completed

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

NCT02728596

Conditions: Agranulocytosis, Breast Carcinoma In Situ, Breast Diseases, +60 more
Locations: Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States

NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States

Contra Costa Regional Medical Center Martinez, California, United States

Augusta University Medical Center Augusta, Georgia, United States

View all 160 locations

View Trial Details

Completed

4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer

NCT03364348

Conditions: Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +10 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States

View Trial Details

Completed

Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer

NCT03050463

Conditions: Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +17 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States

View Trial Details

Completed

Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors

NCT03039140

Conditions: Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +17 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

NCT01849250

Conditions: Adenocarcinoma, Benign Breast Neoplasm, Breast Carcinoma In Situ, +24 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Columbia University/Herbert Irving Cancer Center New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

eHealth Weight Loss Program in African American Breast Cancer Survivors

NCT02699983

Conditions: Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +17 more
Locations: Rutgers Robert Wood Johnson Medical School New Brunswick, New Jersey, United States

View Trial Details

Completed

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

NCT03112668

Conditions: Breast Diseases, Breast Neoplasms, Colonic Diseases, +80 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer

NCT00470301

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Mount Sinai Medical Center New York, United States

Columbia University Medical Center New York, United States

Weill Medical College of Cornell University New York, United States

View Trial Details

Completed

Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus

NCT02015559

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +11 more
Locations: Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx

NCT02038010

Conditions: Breast Diseases, Breast Neoplasms, HER2-positive Breast Cancer, +9 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details